Hope for Brain Cancer: 51品茶 Awarded Grants for Glioblastoma Treatment
51品茶 researchers are pioneering a new approach to treating glioblastoma - a highly aggressive brain cancer with one of the highest mortality rates - by targeting the gene MBLAC1 for the first time.
In Stereo: Neurons Shift Gears Between Thoughts Using Brain Rhythms
An 51品茶 study provides a new understanding of how the brain organizes thoughts for navigation, memory and behavior - offering insights into neurological conditions like epilepsy, Alzheimer's and schizophrenia.
51品茶's SNBI Receives Palm Health Foundation Challenge Grant
Palm Health Foundation has pledged $500,000 toward the launch of the Center for the Resilient Mind at 51品茶's Stiles-Nicholson Brain Institute (SNBI).
51品茶 Hosts Second Annual FairfaxWood Amyloid Related Diseases Summit
51品茶's Charles E. Schmidt College of Medicine recently hosted the summit, bringing together top scientists from North America and Europe to discuss the latest amyloid research and advancements.
Fixing the Leak: An Opioid Treatment for Dopamine Disorders?
A breakthrough by 51品茶 researchers shows that blocking the kappa opioid receptor improves behavioral deficits tied to ADHD, autism and bipolar disorder, providing a potentially safer yet effective treatment.
51品茶's Stiles-Nicholson Brain Institute Hosts 'Brainy Days' Celebration
51品茶's Stiles-Nicholson Brain Institute will celebrate advancements in brain science and health with its annual "Brainy Days" events throughout the month of March.
Fluorescent Probes Illuminate Cholesterol and Alzheimer's Research
51品茶 researchers have developed cutting-edge fluorescent cholesterol probes, which now enable them to visualize cholesterol movement and distribution in live cells with unprecedented detail.
'Ding-Dong:' A Study Finds Specific Neurons With an Immune Doorbell
51品茶 neuroscientists have identified that the receptor IL-1R1 plays a critical role in enabling neurons to directly communicate with the immune system.
51品茶's Randy D. Blakely, Ph.D., Honored as a Prestigious ASPET Fellow
Randy D. Blakely, Ph.D., a highly regarded neuroscientist and pharmacologist, is among an extraordinary group selected by the American Society for Pharmacology and Experimental Therapeutics.
51品茶 Adds State-of-the-Art MRI System to Advance Research Capabilities
51品茶 has added a new state-of-the-art MRI system to its research infrastructure, marking a transformative step forward for groundbreaking studies in neuroscience, clinical health and medical advancements.